{"cluster": 50, "subcluster": 6, "abstract_summ": "This retrospective study of an institutional cohort including 135 patients with confirmed COVID-19 demonstrates positive outcomes when organizational standards of care consist of evidence-based supportive therapies.As the COVID-19 pandemic worsens, the clinical cancer community is grappling with how to continue providing access to experimental but potentially lifesaving therapies while keeping immunocompromised patients safe.Calls for adherence to evidence-based medicine have emerged during the initial wave of the COVID-19 pandemic but reports of outcomes are lacking.In this situation, useful prognostic parameters and targeted supportive treatment are urgently needed.In several countries, the capacities for intensive care and for support in case of acute respiratory distress syndrome (ARDS) are overstretched, and the mortality is considerable.", "title_summ": "DIC in COVID\u201019: Implications for Prognosis and Treatment?Clinical Outcomes of Coronavirus Disease 2019 With Evidence-based Supportive CareClinical Research Slows as COVID-19 Surges.", "title_abstract_phrases": "This retrospective study of an institutional cohort including 135 patients with confirmed COVID-19 demonstrates positive outcomes when organizational standards of care consist of evidence-based supportive therapies.Clinical Outcomes of Coronavirus Disease 2019 With Evidence-based Supportive CareCalls for adherence to evidence-based medicine have emerged during the initial wave of the COVID-19 pandemic but reports of outcomes are lacking.As the COVID-19 pandemic worsens, the clinical cancer community is grappling with how to continue providing access to experimental but potentially lifesaving therapies while keeping immunocompromised patients safe.In this situation, useful prognostic parameters and targeted supportive treatment are urgently needed.Clinical Research Slows as COVID-19 Surges."}